scholarly article | Q13442814 |
P50 | author | Peter Szodoray | Q42574350 |
Gabriella Szűcs | Q91312009 | ||
Zoltán Szekanecz | Q102229165 | ||
Gyula Szegedi | Q1295375 | ||
P2093 | author name string | Pál Soltész | |
Zoltán Szabó | |||
Andrea Váncsa | |||
György Kerekes | |||
Szilvia Szamosi | |||
Henriett Dér | |||
László Csáthy | |||
P433 | issue | 3 | |
P921 | main subject | rheumatoid arthritis | Q187255 |
adalimumab | Q348260 | ||
vascular disease | Q1266890 | ||
P304 | page(s) | 147-152 | |
P577 | publication date | 2011-03-01 | |
P1433 | published in | Israel Medical Association Journal | Q133979 |
P1476 | title | Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis | |
P478 | volume | 13 |
Q33902895 | Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis |
Q36151574 | Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy |
Q24568196 | Biologics, cardiovascular effects and cancer |
Q42755997 | Inflammation, endothelial function and atherosclerosis in rheumatoid arthritis |
Q42236141 | Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition. |
Q35673987 | Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis |
Q33704086 | Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound |
Q38612651 | Prevention of Stroke in Rheumatoid Arthritis |
Q36088839 | Targeting Tumor Necrosis Factor-α with Adalimumab: Effects on Endothelial Activation and Monocyte Adhesion |
Q92590106 | The impact of rehabilitation frequency on the risk of stroke in patients with rheumatoid arthritis |
Q88979499 | Treat-to-target therapy does not prevent excessive progression of carotid intima media thickness during the first year of therapy in early rheumatoid arthritis |
Q34164481 | Validated methods for assessment of subclinical atherosclerosis in rheumatology |
Q34782535 | Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series). |
Search more.